IUPAC/Chemical Name
1,3,5-Triazine-2,4-diamine, 1-((3,4-dichlorophenyl)methoxy)-1,6-dihydro-6,6-dimethyl- (9CI)
InChi Key
XDTNOYLBDDCJSK-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H15Cl2N5O/c1-12(2)18-10(15)17-11(16)19(12)20-6-7-3-4-8(13)9(14)5-7/h3-5H,6H2,1-2H3,(H4,15,16,17,18)
SMILES Code
NC1=NC(N)=NC(C)(C)N1OCC2=CC=C(Cl)C(Cl)=C2
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
316.19
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Auliff AM, Balu B, Chen N, O'Neil MT, Cheng Q, Adams JH. Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum. PLoS One. 2012;7(7):e40416. doi: 10.1371/journal.pone.0040416. Epub 2012 Jul 9. PubMed PMID: 22792308; PubMed Central PMCID: PMC3392216.
2: Knight DJ, Peters W. The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol. 1980 Aug;74(4):393-404. PubMed PMID: 7006531.
3: Mookherjee S, Howard V, Nzila-Mouanda A, Watkins W, Sibley CH. Identification and analysis of dihydrofolate reductase alleles from Plasmodium falciparum present at low frequency in polyclonal patient samples. Am J Trop Med Hyg. 1999 Jul;61(1):131-40. PubMed PMID: 10432070.
4: O'Neil MT, Korsinczky ML, Gresty KJ, Auliff A, Cheng Q. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase. J Infect Dis. 2007 Aug 1;196(3):467-74. Epub 2007 Jun 20. PubMed PMID: 17597462.
5: Winstanley PA, Mberu EK, Szwandt IS, Breckenridge AM, Watkins WM. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs. Antimicrob Agents Chemother. 1995 Apr;39(4):948-52. PubMed PMID: 7786001; PubMed Central PMCID: PMC162659.
6: Nettleton MJ, Poyser RH, Shorter JH. The cardiovascular effects of two new triazine antimalarials, BRL 50216 (Clociguanil) and BRL 6231. Toxicol Appl Pharmacol. 1974 Feb;27(2):271-82. PubMed PMID: 4854671.
7: Knight DJ, Williamson P. The antimalarial activity of N-benzyloxydihydrotriazines. II. The development of resistance to clociguanil (BRL 50216) and cycloguanil by P. berghei. Ann Trop Med Parasitol. 1980 Aug;74(4):405-13. PubMed PMID: 6450572.
